KUROME THERAPEUTICS
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that target cancer cells that have co-opted immune signaling pathways to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
KUROME THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
Cincinnati, Ohio, United States
Country:
United States
Website Url:
http://www.kurometherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
513-445-3852
Email Addresses:
[email protected]
Total Funding:
15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Fastly Fastly Hosted
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Investors List
Affinity Asset Advisors
Affinity Asset Advisors investment in Series A - Kurome Therapeutics
Queen City Angels
Queen City Angels investment in Series A - Kurome Therapeutics
CincyTech
CincyTech investment in Series A - Kurome Therapeutics
Medicxi
Medicxi investment in Series A - Kurome Therapeutics
CincyTech
CincyTech investment in Seed Round - Kurome Therapeutics
Official Site Inspections
http://www.kurometherapeutics.com
- Host name: 67.227.188.112
- IP address: 67.227.188.112
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Kurome Therapeutics"
Kurome Therapeutics, Inc. | LinkedIn
Kurome Therapeutics, Inc. Biotechnology Research Cincinnati, Ohio 856 followers A preclinical stage company focused on subverting cancer's ability to evade therapy.See details»
Kurome Therapeutics - Crunchbase Company Profile
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy. The company is developing therapies that …See details»
Team - Kurome Therapeutics
A seasoned business and technical management team with more than 50 years of combined experience in pharma and biotech investment and program execution.See details»
Kurome Therapeutics, Inc. Company Profile | Cincinnati, OH ...
Find company research, competitor information, contact details & financial data for Kurome Therapeutics, Inc. of Cincinnati, OH. Get the latest business insights from Dun & Bradstreet.See details»
Kurome Therapeutics, Inc. Overview | SignalHire Company Profile
Organization Website: kurometherapeutics.com : Kurome Therapeutics,... industries Biotech: Headquarters Location: 3536 Edwards Road Suite 100, Cincinnati, Ohio, 45208 US 3536 …See details»
Kurome Therapeutics (USA) Funding: $15M - Medical Startups
Feb 26, 2025 Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic …See details»
Kurome Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Www.kurometherapeutics.com. Startups | Holding Company | 2019 | Ohio, United States | 10-50 | www.kurometherapeutics.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. …See details»
Kurome Therapeutics - Company Profile - Tracxn
Oct 31, 2024 Kurome Therapeutics ranks 23rd among 83 active competitors. 31 of its competitors are funded while 19 have exited. Overall, Kurome Therapeutics and its …See details»
Kurome Therapeutics Company Information - Funding, Investors, …
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Kurome Therapeutics - PitchBook
Kurome Therapeutics General Information Description. Developer of novel therapies designed to target cancer cells with over-activated IRAK1/4-mediated signaling pathways.See details»
Kurome Therapeutics - VentureRadar
Develops novel inhibitors targeting cancer cells with adaptive resistance to chemotherapy, aiming to extend remission and overall survival. " Kuromeis developing combined IRAK1/4 and …See details»
Kurome Therapeutics - Products, Competitors, Financials, …
Kurome Therapeutics is a preclinical stage biotechnology company focused on developing therapies for cancer treatment. Use the CB Insights Platform to explore Kurome …See details»
Kurome Therapeutics - Overview, News & Similar companies
Kurome® Therapeutics is a preclinical stage company developing novel therapies that subvert cancer's ability to evade treatment. Founded on research at Cincinnati Children's Hospital …See details»
Kurome Therapeutics - Medicxi
Launched in 2020, Kurome® Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional …See details»
Kurome Therapeutics - Craft
Kurome Therapeutics is a company that develops therapies for cancer treatment. It offers pre-clinical studies and trials, drug development, medical diagnostics, conventional …See details»
Science - Kurome Therapeutics
OUR SCIENCE A TARGETED APPROACH FOR TREATING HEMATOLOGICAL CANCERS AND BEYOND Kurome Therapeutics is a late preclinical stage company that is developing a …See details»
Kurome Therapeutics, Inc. (Kurome Therapeutics, Inc.) - 药物管线_ …
Entering the clinic in the second half of 2024, KME-0584, an IRAK1/4/panFIt3 Inhibitor is a first in class investigational drug for relapsed/refractory AML and high-risk MDS patients CINCINNATI …See details»
Kurome Therapeutics - VentureRadar
Similar Companies: Prelude Therapeutics USA Privately Held Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical …See details»
Kurome Therapeutics-动脉网
Kurome Therapeutics是一家临床前阶段公司，致力于开发颠覆癌症逃避治疗能力的新型疗法。在辛辛那提儿童医院医学中心与美国国立卫生研究院国家促进转化科学中心 (NCATS) 合作的研 …See details»
Tasman Therapeutics Advancing Oral Ketamine Program to
20 hours ago After an extensive search, biotech industry veteran Dan Browne has been appointed as Tasman CEO in order to advance the company’s neuroscience and …See details»